ARROWHEAD RESEARCH CORP (ARWR) has 167 open-market insider trades by 24 insiders since 2006. Over the last six months insiders net sold $1.2M. The most active filer is Christopher Richard Anzalone, CEO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Christopher Richard Anzalone | CEO | — | 36 | $138.7M | 2026-01-02 |
| Patrick O'Brien | COO | — | 9 | $26.4M | 2026-01-06 |
| Kenneth Allen Myszkowski | CFO | — | 26 | $25.5M | 2025-01-07 |
| Bruce D. Given | COO | — | 16 | $16.2M | 2020-04-28 |
| Michael S. Perry | Dir | — | 6 | $10.3M | 2026-08-18 |
| James C. Hamilton | — | — | 8 | $9.6M | 2026-04-23 |
| David M. Knott Jr. | 10% | — | 4 | $6.0M | 2007-03-21 |
| Douglas B. Given | Dir | — | 14 | $5.8M | 2024-12-17 |
| Martin Javier San | — | — | 4 | $3.7M | 2024-01-05 |
| Peter Brian Leone | VP | — | 1 | $3.5M | 2018-10-19 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Adeoye Y. Olukotun | Director | Sell | $174K | 2026-08-18 |
| Michael S. Perry | Director | Sell | $1.0M | 2026-08-18 |
| Hongbo Lu | Director | Sell | $228K | 2026-05-12 |
| James C. Hamilton | — | Sell | $750K | 2026-04-23 |
| Daniel Joseph Apel | CFO | Sell | $934K | 2026-04-22 |
| James C. Hamilton | Chief Medical Officer | Sell | $642K | 2026-03-05 |
Companies that share insiders with ARWR, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Patrick O'Brien | COO | Sell | $3.1M | 2026-01-05 |
| James C. Hamilton | — | Sell | $2.5M | 2026-01-05 |
| Christopher Richard Anzalone | CEO | Sell | $872K | 2026-01-02 |
| Christopher Richard Anzalone | CEO | Sell | $7.2M | 2025-12-29 |
| Mauro Ferrari | Director | Sell | $527K | 2025-12-26 |
| Christopher Richard Anzalone | CEO | Sell | $3.5M | 2025-12-19 |
| Adeoye Y. Olukotun | Director | Sell | $1.1M | 2025-12-19 |
| William D. Waddill | Director | Sell | $1.1M | 2025-12-19 |
| Victoria Vakiener | Director | Sell | $1.4M | 2025-12-19 |